Novelogics Biotechnology, Inc. logo

Novelogics Biotechnology, Inc.

Novelogics Biotechnology is an early-stage company focused on discovery and development of innovative antibody therapeutics and medical devices to treat multiple types of cancers.

Novelogics is developing first-in-class monoclonal antibody drugs for cancer that are adaptable for use within a medical device for the same therapeutic indications.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://www.novelogics.com
Founded2013
Disease Focus
Development Stage
STOCK CODENon Listed
Address
225-20316 56 Avenue, Langley, British Columbia, V3A3Y7
Vancouver
Canada
Email
Contact Number
+1 778-837-2561

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=” ” connections=”true” suffix=””]

The proprietary technology behind Novelogics innovation involves discovery and development of monoclonal antibodies that targets an undisclosed protein that is involved with the undesirable immune system suppression associated with cancer.

In Aug 2013, Novelogics received a financial contribution from the National Research Council of Canada Industrial Research Assistance Program (NRC-RAP) of up to $ 50,000 to aid in the development of NovelogicsÇ new approach to fighting cancer.